A citation-based method for searching scientific literature

Daniel J Foti, Roman Kotov, Lin T Guey, Evelyn J Bromet. Am J Psychiatry 2010
Times Cited: 124







List of co-cited articles
821 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Theresa H M Moore, Stanley Zammit, Anne Lingford-Hughes, Thomas R E Barnes, Peter B Jones, Margaret Burke, Glyn Lewis. Lancet 2007
36

Effects of cannabis use on outcomes of psychotic disorders: systematic review.
Stanley Zammit, Theresa H M Moore, Anne Lingford-Hughes, Thomas R E Barnes, Peter B Jones, Margaret Burke, Glyn Lewis. Br J Psychiatry 2008
168
27

Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.
Johanna Koskinen, Johanna Löhönen, Hannu Koponen, Matti Isohanni, Jouko Miettunen. Schizophr Bull 2010
189
25

The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
25

Cannabis use and outcome of recent onset psychosis.
Anton Grech, Jim Van Os, Peter B Jones, Shon W Lewis, Robin M Murray. Eur Psychiatry 2005
148
24

Cannabis abuse and the course of recent-onset schizophrenic disorders.
D H Linszen, P M Dingemans, M E Lenior. Arch Gen Psychiatry 1994
469
21

Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
Deepak Cyril D'Souza, Walid Michel Abi-Saab, Steven Madonick, Kimberlee Forselius-Bielen, Anne Doersch, Gabriel Braley, Ralitza Gueorguieva, Thomas B Cooper, John Harrison Krystal. Biol Psychiatry 2005
380
21

Cannabis use and psychosis: a longitudinal population-based study.
J van Os, M Bak, M Hanssen, R V Bijl, R de Graaf, H Verdoux. Am J Epidemiol 2002
517
19

Cannabis use and earlier onset of psychosis: a systematic meta-analysis.
Matthew Large, Swapnil Sharma, Michael T Compton, Tim Slade, Olav Nielssen. Arch Gen Psychiatry 2011
312
19

The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.
Deepak Cyril D'Souza, Edward Perry, Lisa MacDougall, Yola Ammerman, Thomas Cooper, Yu-Te Wu, Gabriel Braley, Ralitza Gueorguieva, John Harrison Krystal. Neuropsychopharmacology 2004
581
19

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Louise Arseneault, Mary Cannon, Richie Poulton, Robin Murray, Avshalom Caspi, Terrie E Moffitt. BMJ 2002
758
17

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.
Stanley Zammit, Peter Allebeck, Sven Andreasson, Ingvar Lundberg, Glyn Lewis. BMJ 2002
479
16

Cannabis and schizophrenia. A longitudinal study of Swedish conscripts.
S Andréasson, P Allebeck, A Engström, U Rydberg. Lancet 1987
653
16

Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study.
Daniel van Dijk, Maarten W J Koeter, Ron Hijman, René S Kahn, Wim van den Brink. Schizophr Res 2012
44
34

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
F M Leweke, D Piomelli, F Pahlisch, D Muhl, C W Gerth, C Hoyer, J Klosterkötter, M Hellmich, D Koethe. Transl Psychiatry 2012
482
15

Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
L Hides, S Dawe, D J Kavanagh, R McD Young. Br J Psychiatry 2006
115
14

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people.
Cécile Henquet, Lydia Krabbendam, Janneke Spauwen, Charles Kaplan, Roselind Lieb, Hans-Ulrich Wittchen, Jim van Os. BMJ 2005
456
14

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.
Marta Di Forti, Hannah Sallis, Fabio Allegri, Antonella Trotta, Laura Ferraro, Simona A Stilo, Arianna Marconi, Caterina La Cascia, Tiago Reis Marques, Carmine Pariante,[...]. Schizophr Bull 2014
209
14

Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
Marta Di Forti, Arianna Marconi, Elena Carra, Sara Fraietta, Antonella Trotta, Matteo Bonomo, Francesca Bianconi, Poonam Gardner-Sood, Jennifer O'Connor, Manuela Russo,[...]. Lancet Psychiatry 2015
272
14

The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
Louisa Degenhardt, Chris Tennant, Stuart Gilmour, David Schofield, Louise Nash, Wayne Hall, Diana McKay. Psychol Med 2007
60
21

Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use.
Ana González-Pinto, Susana Alberich, Sara Barbeito, Miguel Gutierrez, Patricia Vega, Berta Ibáñez, Mahmoud Karim Haidar, Eduard Vieta, Celso Arango. Schizophr Bull 2011
72
18

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.
Avshalom Caspi, Terrie E Moffitt, Mary Cannon, Joseph McClay, Robin Murray, HonaLee Harrington, Alan Taylor, Louise Arseneault, Ben Williams, Antony Braithwaite,[...]. Biol Psychiatry 2005
760
13

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Sagnik Bhattacharyya, Paul D Morrison, Paolo Fusar-Poli, Rocio Martin-Santos, Stefan Borgwardt, Toby Winton-Brown, Chiara Nosarti, Colin M O' Carroll, Marc Seal, Paul Allen,[...]. Neuropsychopharmacology 2010
406
13


The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
Murat Yücel, Emre Bora, Dan I Lubman, Nadia Solowij, Warrick J Brewer, Sue M Cotton, Philippe Conus, Michael J Takagi, Alex Fornito, Stephen J Wood,[...]. Schizophr Bull 2012
167
12


Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.
Tabea Schoeler, Anna Monk, Musa B Sami, Ewa Klamerus, Enrico Foglia, Ruth Brown, Giulia Camuri, A Carlo Altamura, Robin Murray, Sagnik Bhattacharyya. Lancet Psychiatry 2016
122
12

Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up.
John Stirling, Shon Lewis, Richard Hopkins, Colin White. Schizophr Res 2005
95
11

Adverse health effects of non-medical cannabis use.
Wayne Hall, Louisa Degenhardt. Lancet 2009
602
11

Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study.
Rebecca Kuepper, Jim van Os, Roselind Lieb, Hans-Ulrich Wittchen, Michael Höfler, Cécile Henquet. BMJ 2011
174
11

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.
Andrea Giuffrida, F Markus Leweke, Christoph W Gerth, Daniela Schreiber, Dagmar Koethe, Johannes Faulhaber, Joachim Klosterkötter, Daniele Piomelli. Neuropsychopharmacology 2004
330
11

Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
Sagnik Bhattacharyya, Paolo Fusar-Poli, Stefan Borgwardt, Rocio Martin-Santos, Chiara Nosarti, Colin O'Carroll, Paul Allen, Marc L Seal, Paul C Fletcher, José A Crippa,[...]. Arch Gen Psychiatry 2009
176
11

Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.
Arianna Marconi, Marta Di Forti, Cathryn M Lewis, Robin M Murray, Evangelos Vassos. Schizophr Bull 2016
256
11

Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort.
E Manrique-Garcia, S Zammit, C Dalman, T Hemmingsson, S Andreasson, P Allebeck. Psychol Med 2012
87
11

Does change in cannabis use in established psychosis affect clinical outcome?
Christine Barrowclough, Richard Emsley, Emily Eisner, Ruth Beardmore, Til Wykes. Schizophr Bull 2013
24
41

Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial.
Gunnar Faber, Henderikus G O M Smid, Arthur R Van Gool, Lex Wunderink, Robert J van den Bosch, Durk Wiersma. J Clin Psychiatry 2012
23
43

Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR.
Dean F Wong, Hiroto Kuwabara, Andrew G Horti, Vanessa Raymont, James Brasic, Maria Guevara, Weiguo Ye, Robert F Dannals, Hayden T Ravert, Ayon Nandi,[...]. Neuroimage 2010
133
10

Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey.
J C Negrete, W P Knapp, D E Douglas, W B Smith. Psychol Med 1986
183
10

The environment and schizophrenia: the role of cannabis use.
Cécile Henquet, Robin Murray, Don Linszen, Jim van Os. Schizophr Bull 2005
274
10

Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.
I Harrison, E M Joyce, S H Mutsatsa, S B Hutton, V Huddy, M Kapasi, T R E Barnes. Psychol Med 2008
57
17

Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.
Jennifer L Seddon, Max Birchwood, Alex Copello, Linda Everard, Peter B Jones, David Fowler, Tim Amos, Nick Freemantle, Vimal Sharma, Max Marshall,[...]. Schizophr Bull 2016
42
23

Cannabis use and age at onset of schizophrenia.
Natalie D Veen, Jean-Paul Selten, Ingeborg van der Tweel, Wilma G Feller, Hans W Hoek, René S Kahn. Am J Psychiatry 2004
156
9

Cannabis use and misuse prevalence among people with psychosis.
Bob Green, Ross Young, David Kavanagh. Br J Psychiatry 2005
125
9

Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis.
Juan A Galvez-Buccollini, Ashley C Proal, Veronica Tomaselli, Melissa Trachtenberg, Cristinel Coconcea, Jinsoo Chun, Theo Manschreck, Jerry Fleming, Lynn E Delisi. Schizophr Res 2012
47
19

Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.
Michael T Compton, Mary E Kelley, Claire E Ramsay, Makenya Pringle, Sandra M Goulding, Michelle L Esterberg, Tarianna Stewart, Elaine F Walker. Am J Psychiatry 2009
120
9

Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users.
Marta Di Forti, Conrad Iyegbe, Hannah Sallis, Anna Kolliakou, M Aurora Falcone, Alessandra Paparelli, Miriam Sirianni, Caterina La Cascia, Simona A Stilo, Tiago Reis Marques,[...]. Biol Psychiatry 2012
142
9

Elevated endogenous cannabinoids in schizophrenia.
F M Leweke, A Giuffrida, U Wurster, H M Emrich, D Piomelli. Neuroreport 1999
322
9

Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients.
Monica Rais, Wiepke Cahn, Neeltje Van Haren, Hugo Schnack, Esther Caspers, Hilleke Hulshoff Pol, René Kahn. Am J Psychiatry 2008
139
9

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.
D A Regier, M E Farmer, D S Rae, B Z Locke, S J Keith, L L Judd, F K Goodwin. JAMA 1990
9

The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis.
M Lambert, P Conus, D I Lubman, D Wade, H Yuen, S Moritz, D Naber, P D McGorry, B G Schimmelmann. Acta Psychiatr Scand 2005
215
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.